Document:

EX-10.2

 Exhibit 10.2 

REGISTRATION RIGHTS AGREEMENT 

This REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of June 8, 2022 by and among DBV
Technologies S.A., a société anonyme organized under the laws of the French Republic (the “Company”), and the “Investors” named in the Securities Purchase Agreement, dated as of the date hereof, by and
among the Company and the Investors identified on Schedule I attached thereto (the “Purchase Agreement”). Capitalized terms used herein have the respective meanings ascribed thereto in the Purchase Agreement unless otherwise
defined herein. 
 The parties hereby agree as follows: 

1. Certain Definitions. As used in this Agreement, the following terms shall have the following meanings: 

“1933 Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder. 

“1934 Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder. 

“ADSs” means American Depositary Shares, each representing one-half of one Ordinary
Share. 
 “Business Day” means a day, other than a Saturday or Sunday, on which banks in New York are open for the general
transaction of business. 
 “Closing Date” means the last “Closing Date,” as defined in the Purchase Agreement,
with respect to the purchase and sale of all Securities set forth on Schedule I to the Purchase Agreement. 

“Holder” or “Holders” means the holder or holders, as the case may be, from time to time of Registrable
Securities. 
 “Investors” means the Investors identified in the Purchase Agreement and any Affiliate or permitted
transferee of any such Investor who is a subsequent Holder of Registrable Securities. 
 “Ordinary Shares” means the
Company’s ordinary shares, of €0.10 nominal value each and includes ordinary shares in the form of ADSs. 

“Person” means an individual or a corporation, partnership, trust, incorporated or unincorporated association, joint venture,
limited liability company, joint stock company, government (or an agency or political subdivision thereof) or other entity of any kind. 

“Purchased Shares” means the Ordinary Shares purchased by the Investors pursuant to the Purchase Agreement. 

“Prospectus” means (i) the prospectus included in any Registration Statement, as amended or supplemented by any
prospectus supplement, with respect to the terms of the offering of any portion of the Registrable Securities covered by such Registration Statement and by all other amendments and supplements to the prospectus, including post-effective amendments
and all material incorporated by reference in such prospectus, and (ii) any “free writing prospectus” as defined in Rule 405 under the 1933 Act. 

“Register,” “registered” and “registration” refer to a registration made by preparing and
filing a Registration Statement or similar document in compliance with the 1933 Act, and the declaration or ordering of effectiveness of such Registration Statement or document. 

“Registrable Securities” means (i) the Purchased Shares, (ii) the Warrant Shares then issued or issuable upon
exercise of the Warrants (without regard to any exercise limitations therein), and (iii) any other Ordinary Shares issued as a dividend or other distribution with respect to, in exchange for or in replacement of the Purchased

 
Shares or the Warrant Shares, in each case issued and sold pursuant to the Purchase Agreement; provided, however, that any such Registrable Securities shall cease to be Registrable Securities
(and the Company shall not be required to maintain the effectiveness of any, or file another, Registration Statement hereunder with respect thereto) upon the first to occur of (A) a Registration Statement with respect to the sale of such
Registrable Securities being declared effective by the SEC under the 1933 Act and such Registrable Securities having been disposed of by the Holder thereof in accordance with such effective Registration Statement, (B) such Registrable
Securities having been sold in accordance with Rule 144 (or another exemption from the registration requirements of the 1933 Act), (C) such Registrable Securities becoming eligible for resale without volume or manner-of-sale restrictions and without current public information requirements pursuant to Rule 144 and (D) the fifth anniversary of the Closing Date. For the avoidance of doubt, any provision herein
requiring the calculation of the number of Registrable Securities as of any date, or the computation of a percentage of Registrable Securities, shall be deemed to refer to the number of Ordinary Shares constituting Registrable Securities as of such
date, assuming the Warrants are exercisable without regard to any exercise limitations. 
 “Registration Statement” means
any registration statement of the Company under the 1933 Act that covers the resale of any of the Registrable Securities pursuant to the provisions of this Agreement, amendments and supplements to such Registration Statement, including
post-effective amendments, all exhibits and all material incorporated by reference in such Registration Statement. 
 “Required
Investors” means the Investors holding a majority of the Registrable Securities outstanding from time to time. 

“SEC” means the U.S. Securities and Exchange Commission. 

“SEC Guidance” means (i) any publicly-available written or oral guidance of the SEC staff, or any comments, requirements
or requests of the SEC staff and (ii) the 1933 Act. 
 “Securities” means, collectively, the Purchased Shares and the
Warrants. 
 “Selling Stockholder Questionnaire” means the Selling Stockholder Notice and Questionnaire, in the form
attached hereto as Annex B (or similar form reasonably satisfactory to the Company and sufficient in substance for the Company to obtain the information necessary to effect the transactions contemplated by the Transaction Documents). 

“Trading Day” means a day on which the Ordinary Shares are listed, quoted and traded on the Nasdaq Global Select Market in
the form of ADSs; provided, that in the event that the Ordinary Shares in the form of ADSs are not listed or quoted as set forth in the foregoing sentence, then Trading Day shall mean a Business Day. 

“Transaction Documents” means this Agreement and the Purchase Agreement. 

“Warrants” has the meaning ascribed to it in the Purchase Agreement. 

“Warrant Shares” means Ordinary Shares issuable upon exercise of the Warrants. 

2. Registration. 
 (a)
Registration Statements. 
 (i) No later than sixty (60) calendar days after the Closing Date (the “Filing
Deadline”), the Company shall prepare and file with the SEC one Registration Statement covering the resale of all of the Registrable Securities which, for the avoidance of doubt, may also register the sale or issuance of primary securities.
Subject to any SEC comments, such Registration Statement shall include the plan of distribution, substantially in the form and substance attached hereto as Annex A. Such Registration Statement also shall cover, to the extent allowable under
the 1933 Act and the rules promulgated thereunder (including Rule 416), such indeterminate number of additional Ordinary Shares resulting from stock splits, stock dividends or similar transactions with respect to the Registrable Securities. Such
Registration Statement (and each amendment or supplement thereto, and each request for 

 
acceleration of effectiveness thereof) shall be provided in accordance with Section 3(c) to the Investors prior to its filing or other submission. If a Registration Statement covering the
Registrable Securities is not filed with the SEC on or prior to the Filing Deadline, the Company will make pro rata payments to each Investor, as liquidated damages and not as a penalty, in an amount equal to 1% of the aggregate amount paid pursuant
to the Purchase Agreement by such Investor for each 30-day period or pro rata for any portion thereof following the Filing Deadline for which no Registration Statement is filed with respect to the Registrable
Securities. Such payments shall constitute the Investors’ exclusive monetary remedy for such events, but shall not affect the right of the Investors to seek injunctive relief. Such payments shall be made to each Investor in cash no later than
five (5) Business Days after the end of each such 30-day period (the “Payment Date”). Interest shall accrue at the rate of 1% per month on any such liquidated damages payments that shall not be
paid by the Payment Date until such amount is paid in full. Notwithstanding the foregoing, the Company will not be liable for any liquidated damages under this Section 2(a)(i) with respect to any Warrant Shares prior to the issuance thereof.

 (ii) The Company shall take reasonable efforts to register the Registrable Securities on Form
S-3 if such form is available for use by the Company, provided that if at such time the Registration Statement is on Form S-1, the Company shall maintain the
effectiveness of the Registration Statement then in effect until such time as a Registration Statement on Form S-3 covering the Registrable Securities has been declared effective by the SEC. 

(b) Expenses. The Company will pay all expenses associated with each Registration Statement, including filing and printing fees, the
Company’s counsel and accounting fees and expenses, costs associated with clearing the Registrable Securities for sale under applicable state securities laws and listing fees, but excluding discounts, commissions, fees of underwriters, selling
brokers, dealer managers or similar securities industry professionals with respect to the Registrable Securities being sold. Except as provided in Section 6 hereof, the Company shall not be responsible for legal fees incurred by Holders of
Registrable Securities in connection with the performance of its rights and obligations under the Transaction Documents. 
 (c)
Effectiveness. 
 (i) The Company shall use commercially reasonable efforts to have the Registration Statements declared effective
as soon as reasonably practicable after the filing thereof. The Company shall notify the Investors by facsimile or e-mail as promptly as practicable, and in any event, within forty-eight (48) hours, after
any Registration Statement is declared effective and shall simultaneously provide the Investors with access to a copy of any related Prospectus to be used in connection with the sale or other disposition of the securities covered thereby. Subject to
Section 2(d), if (A) a Registration Statement covering the Registrable Securities is not declared effective by the SEC prior to the earlier of (i) ten Business Days after the SEC informs the Company that no review of such Registration
Statement will be made or that the SEC has no further comments on such Registration Statement and (ii) the 60th day after the Closing Date (or the 120th day if the SEC reviews such Registration Statement) (the “Effectiveness
Deadline”), or (B) after a Registration Statement has been declared effective by the SEC, sales cannot be made pursuant to such Registration Statement for any reason (including without limitation by reason of a stop order, or the
Company’s failure to update such Registration Statement), but excluding any Allowed Delay (as defined below) or, if the Registration Statement is on Form S-1, for a period of twenty (20) days
following the date on which the Company files a post-effective amendment to incorporate the Company’s Annual Report on Form 10-K (a “Maintenance Failure”), then the Company will make pro
rata payments to each Investor then holding Registrable Securities, as liquidated damages and not as a penalty, in an amount equal to 1% of the aggregate amount paid pursuant to the Purchase Agreement by such Investor for such Registrable Securities
then held by such Investor for each 30-day period or pro rata for any portion thereof following the date by which such Registration Statement should have been effective (the “Blackout
Period”). Such payments shall constitute the Investors’ exclusive monetary remedy for such events, but shall not affect the right of the Investors to seek injunctive relief. The amounts payable as liquidated damages pursuant to this
paragraph shall be paid in cash no later than five (5) Business Days after each such 30-day period following the commencement of the Blackout Period until the termination of the Blackout Period (the
“Blackout Period Payment Date”). Interest shall accrue at the rate of 1% per month on any such liquidated damages payments that shall not be paid by the Blackout Payment Date until such amount is paid in full. Notwithstanding the
foregoing, the Company will not be liable for any liquidated damages under this Section 2(c)(i) with respect to any Warrant Shares prior to the issuance thereof. 

 (ii) Notwithstanding anything to the contrary contained herein, (i) the Company shall
not be required to file a Registration Statement (or any amendment thereto) or, if a Registration Statement has been filed but not declared effective by the SEC, request effectiveness of such Registration Statement, for a period of up to forty-five
(45) days, if (A) the Company determines in good faith that a postponement is in the best interest of the Company and its stockholders generally due to a pending transaction involving the Company (including a pending securities offering by
the Company, or any proposed financing, acquisition, merger, tender offer, business combination, corporate reorganization, consolidation or other significant transaction involving the Company), (B) the Company determines such registration would
render the Company unable to comply with applicable securities laws, (C) the Company determines such registration would require disclosure of material information that the Company has a bona fide business purpose for preserving as confidential,
or (D) audited financial statements as of a date other than the fiscal year end of the Company would be required to be prepared; and (ii) the Company may, upon written notice to any Holder of Registrable Securities included in a
Registration Statement, suspend the use of any Registration Statement, including any Prospectus that forms a part of a Registration Statement, if the Company (X) determines that it would be required to make disclosure of material information in
the Registration Statement that the Company has a bona fide business purpose for preserving as confidential, (Y) the Company determines it must amend or supplement the Registration Statement or the related Prospectus so that such Registration
Statement or Prospectus shall not include an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the case of the Prospectus in light of the circumstances
under which they were made, not misleading or (Z) the Company has experienced or is experiencing some other material non-public event, including a pending transaction involving the Company, the disclosure
of which at such time, in the good faith judgment of the Company, would adversely affect the Company; provided, however, in no event shall Holders of Registrable Securities be suspended from selling Registrable Securities pursuant to the
Registration Statement for a period that exceeds 30 consecutive Trading Days or 60 total Trading Days in any 180-day period (any such suspension contemplated by this Section 2(c)(ii), an “Allowed
Delay”). Upon disclosure of such information or the termination of the condition described above, the Company shall provide prompt notice to Holders whose Registrable Securities are included in the Registration Statement, and shall promptly
terminate any suspension of sales it has put into effect and shall take such other reasonable actions to permit registered sales of Registrable Securities as contemplated hereby. 

(d) Rule 415; Cutback. If at any time the SEC takes the position that the offering of some or all of the Registrable Securities in a
Registration Statement is not eligible to be made on a delayed or continuous basis under the provisions of Rule 415 under the 1933 Act (provided, however, the Company shall be obligated to use commercially reasonable efforts to advocate with the SEC
for the registration of all of the Registrable Securities in accordance with the SEC Guidance, including without limitation, Compliance and Disclosure Interpretation 612.09) or requires any Investor to be named as an “underwriter,” the
Company shall (i) promptly notify each Holder of Registrable Securities thereof and (ii) make commercially reasonable efforts to persuade the SEC that the offering contemplated by such Registration Statement is a valid secondary offering
and not an offering “by or on behalf of the issuer” as defined in Rule 415 and that none of the Investors is an “underwriter.” The Investors shall have the right to select one legal counsel designated by the Required Investors,
at such Investors’ expense, to review and oversee any registration or matters pursuant to this Section 2(d), including participation in any meetings or discussions with the SEC regarding the SEC’s position and to comment on any
written submission made to the SEC with respect thereto. No such written submission with respect to this matter shall be made to the SEC to which the Investors’ counsel reasonably objects. In the event that, despite the Company’s
commercially reasonable efforts and compliance with the terms of this Section 2(d), the SEC refuses to alter its position, the Company shall (i) remove from such Registration Statement such portion of the Registrable Securities (the
“Cut Back Shares”) as provided below and/or (ii) agree to such restrictions and limitations on the registration and resale of the Registrable Securities as the SEC may require to assure the Company’s compliance with the
requirements of Rule 415 (collectively, the “SEC Restrictions”). Unless otherwise directed in writing by a Holder as to its Registrable Securities, the number of Registrable Securities to be registered on such Registration Statement
will be reduced as follows (unless the SEC Restrictions otherwise require or provide or the Holders otherwise agree): 
  

	 	a.	 First, the Company shall reduce or eliminate any securities to be included other than Registrable Securities;

  

	 	b.	 Second, the Company shall reduce Registrable Securities represented by Warrant Shares (applied, in the case
that some Warrant Shares may be registered, to the Holders on a pro rata basis based on the total number of unregistered Warrant Shares held by such Holders); and 

	 	c.	 Third, the Company shall reduce Registrable Securities represented by Purchased Shares (applied, in the case
that some Purchased Shares may be registered, to the Holders on a pro rata basis based on the total number of unregistered Purchased Shares held by such Holders). 

No liquidated damages shall accrue as to any Cut Back Shares until such date as the Company is able to effect the registration of such Cut Back Shares in
accordance with any SEC Restrictions applicable to such Cut Back Shares (such date, the “Restriction Termination Date”). In furtherance of the foregoing, each Investor shall provide the Company with prompt written notice of its sale
of substantially all of the Registrable Securities under such Registration Statement such that the Company will be able to file one or more additional Registration Statements covering the Cut Back Shares. From and after the Restriction Termination
Date applicable to any Cut Back Shares, all of the provisions of this Section 2 (including the Company’s obligations with respect to the filing of a Registration Statement and its obligations to use reasonable efforts to have such
Registration Statement declared effective within the time periods set forth herein and the liquidated damages provisions relating thereto) shall again be applicable to such Cut Back Shares; provided, however, that (i) the Filing Deadline for
such Registration Statement including such Cut Back Shares shall be ten (10) Business Days after such Restriction Termination Date, and (ii) the date by which the Company is required to obtain effectiveness with respect to such Cut Back
Shares shall be the 60th day immediately after the Restriction Termination Date (or the 120th day if the SEC reviews such Registration Statement). 

(e) Other Limitations. Notwithstanding any other provision herein or in the Purchase Agreement, (i) the Filing Deadline and each
Effectiveness Deadline for a Registration Statement shall be extended and any Maintenance Failure shall be automatically waived by no action of the Investors, in each case, without default by or liquidated damages payable by the Company to an
Investor hereunder in the event that the Company’s failure to make such filing or obtain such effectiveness or a Maintenance Failure results from the failure of such Investor to timely provide the Company with information requested by the
Company and necessary to complete a Registration Statement in accordance with the requirements of the 1933 Act (in which case any such deadline would be extended, and a Maintenance Failure waived, with respect to all Registrable Securities until
such time as the Investor provides such requested information), it being understood that the failure of such Investor to timely provide such information to the Company shall not affect the rights of other Investors herein, and (ii) in no event
shall the aggregate amount of liquidated damages (or interest thereon) paid under this Agreement to any Investor exceed, in the aggregate, 5% of the aggregate purchase price of the Securities purchased by such Investor under the Purchase Agreement
or pursuant to the exercise of the Warrants. 
 3. Company Obligations. The Company will use commercially reasonable efforts to
effect the registration of the Registrable Securities in accordance with the terms hereof, and pursuant thereto the Company will, as expeditiously as possible: 

(a) use commercially reasonable efforts to cause such Registration Statement to become effective and to remain continuously effective until
such time as there are no longer Registrable Securities held by the Investors (the “Effectiveness Period”) and advise the Investors promptly in writing when the Effectiveness Period has expired; 

(b) prepare and file with the SEC such amendments and post-effective amendments to such Registration Statement and the related Prospectus as
may be necessary to keep such Registration Statement effective for the Effectiveness Period and to comply with the provisions of the 1933 Act and the 1934 Act with respect to the distribution of all of the Registrable Securities covered thereby;

 (c) provide via email to the Investors who have supplied the Company with email addresses each Registration Statement and all amendments
and supplements thereto not less than three (3) Trading Days prior to their filing with the SEC and reflect in each such document when so filed with the SEC such comments regarding the Investors and the plan of distribution as the Investors may
reasonably and promptly propose no later than two (2) Trading Days after the Investors have been so furnished with copies of such documents as aforesaid; 

(d) furnish to each Investor whose Registrable Securities are included in any Registration Statement (i) promptly after the same is
prepared and filed with the SEC, if requested by such Investor, one (1) copy of any Registration Statement and any amendment thereto, each preliminary prospectus and Prospectus and each amendment or supplement thereto, and each letter written
by or on behalf of the Company to the SEC or the staff of the SEC, and each item of correspondence from the SEC or the staff of the SEC, in each case relating to such Registration Statement (other than any portion of any thereof which contains
information for which the Company has sought confidential 

 
treatment), and (ii) such number of copies of a Prospectus, including a preliminary prospectus, and all amendments and supplements thereto and such other documents as each Investor may
reasonably request in order to facilitate the disposition of the Registrable Securities owned by such Investor (it being understood and agreed that such documents, or access thereto, may be provided electronically); 

(e) use commercially reasonable efforts to (i) prevent the issuance of any stop order or other suspension of effectiveness and,
(ii) if such order is issued, obtain the withdrawal of any such order at the earliest possible moment; 
 (f) prior to any public
offering of Registrable Securities, use reasonable best efforts to assist or cooperate with the Investors and their counsel in connection with their registration or qualification of such Registrable Securities for the offer and sale under the
securities or blue sky laws of such jurisdictions reasonably requested by the Investors; provided, however, that the Company shall not be required in connection therewith or as a condition thereto to (i) qualify to do business in any
jurisdiction where it would not otherwise be required to qualify but for this Section 3(f), (ii) subject itself to general taxation in any jurisdiction where it would not otherwise be so subject but for this Section 3(f), or
(iii) file a general consent to service of process in any such jurisdiction; 
 (g) use commercially reasonable efforts to cause all
Registrable Securities covered by a Registration Statement to be listed on The Nasdaq Global Select Market (or the primary securities exchange, interdealer quotation system or other market on which the Ordinary Shares are then listed); 

(h) promptly notify the Investors, at any time prior to the end of the Effectiveness Period, upon discovery that, or upon the happening of any
event as a result of which, the Prospectus contains an untrue statement of a material fact or omits to state any material fact required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances
then existing, and as promptly as reasonably practicable, prepare, file with the SEC and furnish to such Holder a supplement to or an amendment of such Prospectus as may be necessary so that such Prospectus shall not include an untrue statement of a
material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances then existing; 

(i) comply with all applicable rules and regulations of the SEC under the 1933 Act and the 1934 Act, including, without limitation, Rule 172
under the 1933 Act, file any final Prospectus, including any supplement or amendment thereof, with the SEC pursuant to Rule 424 under the 1933 Act, promptly inform the Investors in writing if, at any time during the Effectiveness Period, the Company
does not satisfy the conditions specified in Rule 172 and, as a result thereof, the Investors are required to deliver a Prospectus in connection with any disposition of Registrable Securities and take such other actions as may be reasonably
necessary to facilitate the registration of the Registrable Securities hereunder; and 
 (j) with a view to making available to the
Investors the benefits of Rule 144 (or its successor rule) and any other rule or regulation of the SEC that may at any time permit the Investors to sell Ordinary Shares to the public without registration, the Company covenants and agrees to:
(i) make and keep public information available, as those terms are understood and defined in Rule 144, until the earlier of (A) six months after such date as all of the Registrable Securities may be sold without restriction by the Holders
thereof pursuant to Rule 144 or any other rule of similar effect or (B) such date as there are no longer Registrable Securities; (ii) file with the SEC in a timely manner all reports and other documents required of the Company under the
1934 Act; and (iii) furnish electronically to each Investor upon request, as long as such Investor owns any Registrable Securities, (A) a written statement by the Company that it has complied with the reporting requirements of the 1934
Act, (B) a copy of or electronic access to the Company’s most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q, and (C) such other
information as may be reasonably requested in order to avail such Investor of any rule or regulation of the SEC that permits the selling of any such Registrable Securities without registration. 

4. Due Diligence Review; Information. If any Investor is required under applicable securities laws to be described in a Registration
Statement as an “underwriter,” the Company shall, upon reasonable prior notice, make available, during normal business hours, for inspection and review by the Investors, advisors to and representatives of the Investors (who may or may not
be affiliated with the Investors and who are reasonably acceptable to the Company) (collectively, the “Inspectors”), all pertinent financial and other records, and all other corporate documents and

 
properties of the Company (collectively, the “Records”) as may be reasonably necessary for the purpose of such review, and cause the Company’s officers, directors and
employees, within a reasonable time period, to supply all such information reasonably requested by the Inspectors (including, without limitation, in response to all questions and other inquiries reasonably made or submitted by any of them), prior to
and from time to time after the filing and effectiveness of such Registration Statement for the sole purpose of enabling such Investor and its accountants and attorneys to conduct such due diligence solely for the purpose of establishing a due
diligence defense to underwriter liability under the 1933 Act; provided, however, that each Inspector shall agree to hold in strict confidence and shall not make any disclosure (except to such Investor) or use of any Record or other information
which the Company determines in good faith to be confidential, and of which determination the Inspectors are so notified, unless (a) the disclosure of such Records is necessary to avoid or correct a misstatement or omission in any Registration
Statement or is otherwise required under the 1933 Act, (b) the release of such Records is ordered pursuant to a final, non-appealable subpoena or order from a court or government body of competent
jurisdiction, or (c) the information in such Records has been made generally available to the public other than by disclosure in violation of this Agreement or the Purchase Agreement. Each Investor agrees that it shall, upon learning that
disclosure of such Records is sought in or by a court or governmental body of competent jurisdiction or through other means, give prompt notice to the Company and allow the Company, at its expense, to undertake appropriate action to prevent
disclosure of, or to obtain a protective order for, the Records deemed confidential. Nothing herein (or in any other confidentiality agreement between the Company and any Investor) shall be deemed to limit the Investors’ ability to sell
Registrable Securities in a manner which is otherwise consistent with applicable laws and regulations. 
 Notwithstanding the foregoing, the
Company shall not disclose material nonpublic information to the Investors, or to advisors to or representatives of the Investors, unless prior to disclosure of such information the Company identifies such information as being material nonpublic
information and provides the Investors, such advisors and representatives with the opportunity to accept or refuse to accept such material nonpublic information for review and any Investor wishing to obtain such information enters into an
appropriate confidentiality agreement with the Company with respect thereto. 
 5. Obligations of the Investors. 

(a) Each Investor shall execute and deliver a Selling Stockholder Questionnaire prior to the Closing Date. Each Investor shall additionally
furnish in writing to the Company such other information regarding itself, the Registrable Securities held by it and the intended method of disposition of the Registrable Securities held by it, as shall be reasonably required to effect the
registration of such Registrable Securities and shall execute such documents in connection with such registration as the Company may reasonably request. At least seven (7) Business Days prior to the first anticipated filing date of any
Registration Statement, the Company shall notify each Investor of the additional information the Company requires from such Investor if such Investor elects to have any of the Registrable Securities included in such Registration Statement (the
“Registration Information Notice”). An Investor shall provide such information to the Company no later than five (5) Business Days following receipt of a Registration Information Notice if such Investor elects to have any of
the Registrable Securities included in such Registration Statement. It is agreed and understood that it shall be a condition precedent to the obligations of the Company to complete the registration pursuant to this Agreement with respect to the
Registrable Securities of a particular Investor that (i) such Investor furnish to the Company such information regarding itself, the Registrable Securities held by it and the intended method of disposition of the Registrable Securities held by
it as shall be reasonably required to effect the effectiveness of the registration of such Registrable Securities, and (ii) such Investor execute such documents in connection with such registration as the Company may reasonably request,
including, without limitation, a waiver of its registration rights hereunder to the extent an Investor elects not to have any of its Registrable Securities included in a Registration Statement. 

(b) Each Investor, by its acceptance of the Registrable Securities, agrees to cooperate with the Company as reasonably requested by the
Company in connection with the preparation and filing of a Registration Statement hereunder, unless such Investor has notified the Company in writing of its election to exclude all of its Registrable Securities from such Registration Statement. 

(c) Each Investor agrees that, upon receipt of any notice from the Company of either (i) the commencement of an Allowed Delay pursuant to
Section 2(c)(ii) or (ii) the happening of an event pursuant to Section 3(h) hereof, such Investor will immediately discontinue disposition of Registrable Securities pursuant to any Registration Statement covering such Registrable
Securities, until the Investor is advised by the Company that such dispositions may again be made. 

 (d) Each Investor covenants and agrees that it will comply with the prospectus delivery
requirements of the 1933 Act as applicable to it or an exemption therefrom in connection with sales of Registrable Securities pursuant to any Registration Statement. 

6. Indemnification. 
 (a)
Indemnification by the Company. The Company will indemnify and hold harmless each Investor and its officers, directors, members, managers, partners, trustees, employees and agents and other representatives, successors and assigns, and each
other Person, if any, who controls such Investor (within the meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act) and the officers, directors, partners, members, managers, trustees and employees of each such controlling
Person, against any losses, claims, damages or liabilities, joint or several, to which they may become subject under the 1933 Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or
are based upon: (i) any untrue statement or alleged untrue statement or omission or alleged omission of any material fact contained in any Registration Statement, any preliminary Prospectus or final Prospectus, or any amendment or supplement
thereof, (ii) any violation or alleged violation by the Company of the 1933 Act, the 1934 Act or any state securities law, or any rule or regulation thereunder, in connection with the performance of its obligations under this Agreement;
provided, however, that the Company will not be liable in any such case if and to the extent that any such loss, claim, damage or liability arises out of or is based upon (i) an untrue statement or alleged untrue statement or omission or
alleged omission so made in conformity with information furnished by such Investor or any such controlling person in writing specifically for use in such Registration Statement or Prospectus, (ii) the use by an Investor of an outdated or
defective Prospectus after the Company has notified such Investor in writing that such Prospectus is outdated or defective or (iii) an Investor’s failure to send or give a copy of the Prospectus or supplement (as then amended or
supplemented), if required (and not exempted) to the Persons asserting an untrue statement or omission or alleged untrue statement or omission at or prior to the written confirmation of the sale of Registrable Securities. 

(b) Indemnification by the Investors. Each Investor agrees, severally but not jointly, to indemnify and hold harmless, to the fullest
extent permitted by law, the Company, its directors, officers, employees, stockholders and each person who controls the Company (within the meaning of the 1933 Act) against any losses, claims, damages, liabilities and expense (including reasonable
attorney fees) resulting from any untrue statement of a material fact or any omission of a material fact required to be stated in any Registration Statement or Prospectus or preliminary Prospectus or amendment or supplement thereto or necessary to
make the statements therein not misleading, to the extent, but only to the extent, that such untrue statement or omission is contained in any information regarding such Investor and furnished in writing by such Investor to the Company specifically
for inclusion in such Registration Statement or Prospectus or amendment or supplement thereto. In no event shall the liability of an Investor be greater than the dollar amount of the proceeds received by such Investor upon the sale of the
Registrable Securities included in such Registration Statement giving rise to such indemnification obligation. 
 (c) Conduct of
Indemnification Proceedings. Any person entitled to indemnification hereunder shall (i) give prompt notice to the indemnifying party of any claim with respect to which it seeks indemnification and (ii) permit such indemnifying party to
assume the defense of such claim with counsel reasonably satisfactory to the indemnified party; provided, that any person entitled to indemnification hereunder shall have the right to employ separate counsel and to participate in the defense of such
claim, but the fees and expenses of such counsel shall be at the expense of such person unless (A) the indemnifying party has agreed to pay such fees or expenses, (B) the indemnifying party shall have failed to assume the defense of such
claim and employ counsel reasonably satisfactory to such person or (C) in the reasonable judgment of any such person, based upon written advice of its counsel, a conflict of interest exists between such person and the indemnifying party with
respect to such claims (in which case, if the person notifies the indemnifying party in writing that such person elects to employ separate counsel at the expense of the indemnifying party, the indemnifying party shall not have the right to assume
the defense of such claim on behalf of such person); and provided, further that the failure of any indemnified party to give notice as provided herein shall not relieve the indemnifying party of its obligations hereunder, except to the extent that
such failure to give notice shall materially adversely affect the indemnifying party in the defense of any such claim or litigation. It is understood that the indemnifying party shall not, in connection with any proceeding in the same jurisdiction,
be liable 

 
for fees or expenses of more than one separate firm of attorneys at any time for all such indemnified parties. No indemnifying party will, except with the consent of the indemnified party, which
shall not be unreasonably withheld or conditioned, consent to entry of any judgment or enter into any settlement that does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of a release
from all liability in respect of such claim or litigation. 
 (d) Contribution. If for any reason the indemnification provided for in
the preceding paragraphs (a) and (b) is unavailable to an indemnified party or insufficient to hold it harmless, other than as expressly specified therein, then the indemnifying party shall contribute to the amount paid or payable by the
indemnified party as a result of such loss, claim, damage or liability in such proportion as is appropriate to reflect the relative fault of the indemnified party and the indemnifying party, as well as any other relevant equitable considerations. No
person guilty of fraudulent misrepresentation within the meaning of Section 11(f) of the 1933 Act shall be entitled to contribution from any person not guilty of such fraudulent misrepresentation. In no event shall the contribution obligation
of a Holder of Registrable Securities be greater in amount than the dollar amount of the proceeds (net of all expenses paid by such Holder in connection with any claim relating to this Section 6 and the amount of any damages such Holder has
otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission) received by it upon the sale of the Registrable Securities giving rise to such contribution obligation. 

7. Miscellaneous. 
 (a)
Amendments and Waivers. This Agreement may be amended only by a writing signed by the Company and the Required Investors. Notwithstanding the foregoing, this Agreement may not be amended and the observance of any term of this Agreement may
not be waived with respect to any Investor without the written consent of such Investor unless such amendment or waiver applies to all Investors in the same fashion. The Company may take any action herein prohibited, or omit to perform any act
herein required to be performed by it, only if the Company shall have obtained the written consent to such amendment, action or omission to act, of the Required Investors and such amendment, action or omission is applicable to, or impacts, all
Investors in the same fashion. 
 (b) Notices. All notices and other communications provided for or permitted hereunder shall be made
as set forth in Section 8 of the Purchase Agreement. 
 (c) Assignments and Transfers by Investors. The provisions of this
Agreement shall be binding upon and inure to the benefit of the Investors and their respective successors and permitted assigns. An Investor may transfer or assign, in whole or from time to time in part, to one or more persons its rights hereunder
(but only with all related obligations) in connection with the transfer of Registrable Securities by such Investor to such person, provided that (i) the Investor agrees in writing with the transferee or assignee to assign such rights and a copy
of such agreement is furnished to the Company within a reasonable time after such assignment; (ii) the Company is, within a reasonable time after such transfer or assignment, furnished with written notice of (A) the name and address of
such transferee or assignee and (B) the securities with respect to which such registration rights are being transferred or assigned; (iii) immediately following such transfer or assignment the further disposition of such securities by the
transferee or assignee is restricted under the 1933 Act or applicable state securities laws; (iv) at or before the time the Company receives the written notice contemplated by clause (ii) of this sentence the transferee or assignee agrees
in writing with the Company to be bound by all of the provisions contained herein; (v) such transfer shall have been made in accordance with the applicable requirements of the Purchase Agreement; and (vi) unless the transferee or assignee
is an Affiliate of, and after such transfer or assignment continues to be an Affiliate of, such Investor, the amount of Registrable Securities transferred or assigned to such transferee or assignee represents at least $5.0 million of
Registrable Securities (based on the then-current market price of the Ordinary Shares). 
 (d) Assignments and Transfers by the
Company. This Agreement may not be assigned by the Company (whether by operation of law or otherwise) without the prior written consent of the Required Investors, provided, however, that in the event that the Company is a party to a merger,
consolidation, share exchange or similar business combination transaction in which the Ordinary Shares are converted into the equity securities of another Person, from and after the effective time of such transaction, such Person shall, by virtue of
such transaction, be deemed to have assumed the obligations of the Company hereunder, the term “Company” shall be deemed to refer to such Person and the term “Registrable Securities” shall be deemed to include the
securities received by the Investors in connection with such transaction unless such securities are otherwise freely tradable by the Investors after giving effect to such transaction. 

 (e) Benefits of the Agreement. The terms and conditions of this Agreement shall inure
to the benefit of and be binding upon the respective permitted successors and assigns of the parties. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors
and assigns any rights, remedies, obligations, or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. 

(f) Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of
which together shall constitute one and the same instrument. Counterparts may be delivered via electronic mail (including pdf or any electronic signature complying with the U.S. ESIGN Act of 2000, e.g., www.docusign.com) or other transmission method
and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes. 
 (g)
Titles and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in construing or interpreting this Agreement. 

(h) Severability. Any provision of this Agreement that is prohibited or unenforceable in any jurisdiction shall, as to such
jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof but shall be interpreted as if it were written so as to be enforceable to the maximum extent permitted by
applicable law, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction. To the extent permitted by applicable law, the parties hereby waive any provision
of law which renders any provisions hereof prohibited or unenforceable in any respect. 
 (i) Further Assurances. The parties shall
execute and deliver all such further instruments and documents and take all such other actions as may reasonably be required to carry out the transactions contemplated hereby and to evidence the fulfillment of the agreements herein contained. 

(j) Entire Agreement. This Agreement is intended by the parties as a final expression of their agreement and intended to be a complete
and exclusive statement of the agreement and understanding of the parties hereto in respect of the subject matter contained herein. This Agreement supersedes all prior agreements and understandings between the parties with respect to such subject
matter. 
 (k) Governing Law; Consent to Jurisdiction; Waiver of Jury Trial. This Agreement shall be governed by, and construed in
accordance with, the internal laws of the State of New York without regard to the choice of law principles thereof (other than sections 5-1401 and 5-1402 of the General
Obligations Law). Each of the parties hereto irrevocably submits to the exclusive jurisdiction of the courts of the State of New York located in New York County and the United States District Court for the Southern District of New York for the
purpose of any suit, action, proceeding or judgment relating to or arising out of this Agreement and the transactions contemplated hereby. Service of process in connection with any such suit, action or proceeding may be served on each party hereto
anywhere in the world by the same methods as are specified for the giving of notices under this Agreement. Each of the parties hereto irrevocably consents to the jurisdiction of any such court in any such suit, action or proceeding and to the laying
of venue in such court. Each party hereto irrevocably waives any objection to the laying of venue of any such suit, action or proceeding brought in such courts and irrevocably waives any claim that any such suit, action or proceeding brought in any
such court has been brought in an inconvenient forum. To the extent that the Company has or hereafter may acquire any immunity (on the grounds of sovereignty or otherwise) from the jurisdiction of any court or from any legal process with respect to
itself or its property, the Company irrevocably waives, to the fullest extent permitted by law, such immunity in respect of any such suit, action or proceeding. EACH OF THE PARTIES HERETO WAIVES ANY RIGHT TO REQUEST A TRIAL BY JURY IN ANY LITIGATION
WITH RESPECT TO THIS AGREEMENT AND REPRESENTS THAT COUNSEL HAS BEEN CONSULTED SPECIFICALLY AS TO THIS WAIVER. 
 (l) Interpretation.
Wherever required by the context of this Agreement, the singular shall include the plural and vice versa, and the masculine gender shall include the feminine and neuter genders and vice versa, and references to any agreement, document or instrument
shall be deemed to refer to such agreement, document or instrument as amended, supplemented or modified from time to time. All article, section, paragraph or clause 

 
references not attributed to a particular document shall be references to such parts of this Agreement, and all exhibit, annex, letter and schedule references not attributed to a particular
document shall be references to such exhibits, annexes, letters and schedules to this Agreement. In addition, the word “or” is not exclusive; the words “including,” “includes,” “included” and
“include” are deemed to be followed by the words “without limitation”; and the terms “herein,” “hereof” and “hereunder” and other words of similar import refer to this Agreement as a whole and not to
any particular section, paragraph or subdivision. 
 (m) Independent Nature of Investors’ Obligations and Rights. The
obligations of each Investor hereunder are several and not joint with the obligations of any other Investor hereunder, and no Investor shall be responsible in any way for the performance of the obligations of any other Holder hereunder. Nothing
contained herein or in any other agreement or document delivered at any closing, and no action taken by any Investor pursuant hereto or thereto, shall be deemed to constitute the Investors as a partnership, an association, a joint venture or any
other kind of group or entity, or create a presumption that the Investors are in any way acting in concert or as a group or entity with respect to such obligations or the transactions contemplated by this Agreement or any other matters, and the
Company acknowledges that the Investors are not acting in concert or as a group, and the Company shall not assert any such claim, with respect to such obligations or transactions. Each Investor shall be entitled to protect and enforce its rights,
including without limitation the rights arising out of this Agreement, and it shall not be necessary for any other Investor to be joined as an additional party in any proceeding for such purpose. The use of a single agreement with respect to the
obligations of the Company contained was solely in the control of the Company, not the action or decision of any Investor, and was done solely for the convenience of the Company and not because it was required or requested to do so by any Investor.
It is expressly understood and agreed that each provision contained in this Agreement is between the Company and an Investor, solely, and not between the Company and the Investors collectively and not between and among Investors. 

[remainder of page intentionally left blank] 

 IN WITNESS WHEREOF, the parties have executed this Agreement or caused their duly authorized
officers to execute this Agreement as of the date first above written. 
  

			
	DBV TECHNOLOGIES S.A.
		
	By:	 	/s/ Daniel Tassé
	Name:	 	Daniel Tassé
	Title:	 	Chief Executive Officer

 [Signature Page to Registration Rights Agreement] 

 IN WITNESS WHEREOF, the parties have executed this Agreement or caused their duly authorized
officers to execute this Agreement as of the date first above written. 
  

			
	INVESTOR:
	
	667, L.P.
	
	BY: BAKER BROS. ADVISORS LP, management company and investment adviser to 667, L.P., pursuant to authority granted to it by Baker Biotech Capital, L.P., general partner to 667, L.P., and not as the general
partner.
		
	By:	 	/s/ Scott Lessing

 
			
	Name:	 	Scott Lessing
	Title:	 	President

 [Signature Page to Registration Rights Agreement] 

 IN WITNESS WHEREOF, the parties have executed this Agreement or caused their duly authorized
officers to execute this Agreement as of the date first above written. 
  

			
	INVESTOR:
	
	BAKER BROTHERS LIFE SCIENCES, L.P.
	
	By: BAKER BROS. ADVISORS LP, management company and investment adviser to Baker BrothersLife Sciences, L.P., pursuant to authority granted to it by Baker Brothers Life Sciences Capital, L.P., general partner to Baker
Brothers Life Sciences, L.P., and not as the general partner.
		
	By:	 	/s/ Scott Lessing

 
			
	Name:	 	Scott Lessing
	Title:	 	President

 [Signature Page to Registration Rights Agreement] 

 IN WITNESS WHEREOF, the parties have executed this Agreement or caused their duly authorized
officers to execute this Agreement as of the date first above written. 
  

			
	INVESTOR:
	
	BPIFRANCE PARTICIPATIONS
		
	By:	 	/s/ Mailys Ferrere

 
			
	Name: Mailys Ferrere
	Title: Directrice Pôle Investissement Large Venture Authorised Signatory
	
	Address:
	
	 27-31 avenue du Général Leclerc

94710 Maisons-Alfort Cedex
 France

 [Signature Page to Registration Rights Agreement] 

 IN WITNESS WHEREOF, the parties have executed this Agreement or caused their duly authorized
officers to execute this Agreement as of the date first above written. 
  

	
	INVESTOR:
	
	Braidwell Partners Master Fund LP
	
	By its Investment Manager, Braidwell LP
	
	/s/ Colin Bettison
	Colin Bettison
	Head of Finance & Operations
	
	/s/ Manish K. Mital
	Manish K. Mital
	Chief Operating Officer & General Counsel

 [Signature Page to Registration Rights Agreement] 

 IN WITNESS WHEREOF, the parties have executed this Agreement or caused their duly authorized
officers to execute this Agreement as of the date first above written. 
  

			
	INVESTOR: FAIRMOUNT HEALTHCARE FUND L.P.
		
	By:	 	/s/ Peter Harwin

 
			
	Print Name:	 	Peter Harwin

 
			
	Title:	 	Managing Member

 [Signature Page to Registration Rights Agreement] 

 IN WITNESS WHEREOF, the parties have executed this Agreement or caused their duly authorized
officers to execute this Agreement as of the date first above written. 
  

			
	INVESTOR: FAIRMOUNT HEALTHCARE FUND II L.P.
		
	By:	 	/s/ Peter Harwin

 
			
	Print Name:	 	Peter Harwin

 
			
	Title:	 	Managing Member

 [Signature Page to Registration Rights Agreement] 

 IN WITNESS WHEREOF, the parties have executed this Agreement or caused their duly authorized
officers to execute this Agreement as of the date first above written. 
  

			
	INVESTOR: Invus Public Equities, L.P.
		
	By:	 	/s/ Khalil Barrage

 
			
	Print Name:	 	Khalil Barrage

 
			
	Title:	 	Vice President of the General Partner

 [Signature Page to Registration Rights Agreement] 

 IN WITNESS WHEREOF, the parties have executed this Agreement or caused their duly authorized
officers to execute this Agreement as of the date first above written. 
  

			
	INVESTOR:
	
	RA CAPITAL HEALTHCARE FUND, L.P.
	
	By: RA Capital Healthcare Fund GP, LLC
	Its: General Partner
		
	By:	 	/s/ Peter Kolchinsky

 
			
	Name:	 	Peter Kolchinsky
	Title:	 	Manager

 [Signature Page to Registration Rights Agreement] 

 IN WITNESS WHEREOF, the parties have executed this Agreement or caused their duly authorized
officers to execute this Agreement as of the date first above written. 
  

			
	INVESTOR:
	
	VENROCK HEALTHCARE CAPITAL PARTNERS EG, L.P.
	
	By: VHCP Management EG, LLC, its general partner
		
	By:	 	/s/ Nimish Shah
	Name:	 	Nimish Shah
	Title:	 	Authorized Signatory
	
	VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P.
	
	By: VHCP Management III, LLC, its general partner
	
	By: VR Advisor, LLC, its manager
	
	VHCP CO-INVESTMENT HOLDINGS III, LLC
	
	By: VHCP Management III, LLC, its manager
	
	By: VR Advisor, LLC, its manager
		
	By:	 	/s/ Nimish Shah
	Name:	 	Nimish Shah
	Title:	 	Authorized Signatory
	
	VENROCK HEALTHCARE CAPITAL PARTNERS II, L.P.
	
	By: VHCP Management II, LLC, its general partner
	
	By: VR Advisor, LLC, its manager
	
	VHCP CO-INVESTMENT HOLDINGS II, LLC
	
	By: VHCP Management II, LLC, its manager
	
	By: VR Advisor, LLC, its manager
		
	By:	 	/s/ Nimish Shah
	Name:	 	Nimish Shah
	Title:	 	Authorized Signatory

 [Signature Page to Registration Rights Agreement] 

 IN WITNESS WHEREOF, the parties have executed this Agreement or caused their duly authorized
officers to execute this Agreement as of the date first above written. 
  

			
	Vivo Opportunity Fund Holdings, L.P.
	
	By: Vivo Opportunity, LLC, General Partner
		
	By:	 	/s/ Gaurav Aggarwal

 
			
	Name:	 	Gaurav Aggarwal
	Title:	 	Managing Member

 [Signature Page to Registration Rights Agreement] 

 Annex A 

Plan of Distribution 
 Each
Selling Stockholder (the “Selling Stockholders”) of the securities and any of their pledgees, assignees and successors-in-interest may, from time to
time, sell any or all of their securities covered hereby on The Nasdaq Global Select Market or any other stock exchange, market or trading facility on which the securities are traded or in private transactions. These sales may be at fixed or
negotiated prices. A Selling Stockholder may use any one or more of the following methods when selling securities: 
  

	 	•	 	 ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;

  

	 	•	 	 block trades in which the broker-dealer will attempt to sell the securities as agent but may position and resell
a portion of the block as principal to facilitate the transaction; 

  

	 	•	 	 purchases by a broker-dealer as principal and resale by the broker-dealer for its account; 

 

	 	•	 	 an exchange distribution in accordance with the rules of the applicable exchange; 

 

	 	•	 	 privately negotiated transactions; 

 

	 	•	 	 settlement of short sales entered into after the effective date of the registration statement of which this
prospectus is a part; 

  

	 	•	 	 in transactions through broker-dealers that agree with the Selling Stockholders to sell a specified number of
such securities at a stipulated price per security; 

  

	 	•	 	 through the writing or settlement of options or other hedging transactions, whether through an options exchange
or otherwise; 

  

	 	•	 	 a combination of any such methods of sale; or 

 

	 	•	 	 any other method permitted pursuant to applicable law. 

The Selling Stockholders may also sell securities under Rule 144 or any other exemption from registration under the Securities Act of 1933, as
amended (the “Securities Act”), if available, rather than under this prospectus. 
 Broker-dealers engaged by the Selling
Stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions or discounts from the Selling Stockholders (or, if any broker-dealer acts as agent for the purchaser of securities, from the
purchaser) in amounts to be negotiated, but, except as set forth in a supplement to this Prospectus, in the case of an agency transaction not in excess of a customary brokerage commission in compliance with FINRA Rule 2121; and in the case of a
principal transaction a markup or markdown in compliance with FINRA IM 2121.01. 
 In connection with the sale of the securities or
interests therein, the Selling Stockholders may enter into hedging transactions with broker-dealers or other financial institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they assume. The
Selling Stockholders may also sell securities short and deliver these securities to close out their short positions, or loan or pledge the securities to broker-dealers that in turn may sell these securities. The Selling Stockholders may also enter
into option or other transactions with broker-dealers or other financial institutions or create one or more derivative securities which require the delivery to such broker-dealer or other financial institution of securities offered by this
prospectus, which securities such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction). 

The Selling Stockholders and any broker-dealers or agents that are involved in selling the securities may be deemed to be
“underwriters” within the meaning of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers or agents and any profit on the resale of the securities purchased by them may be
deemed to be underwriting commissions or discounts under the Securities Act. 
 The Selling Stockholders and any broker-dealers or agents
that are involved in selling the securities may be deemed to be “underwriters” within the meaning of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers or agents and any profit
on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act. Each Selling Stockholder has informed the Company that it does not have any written or oral agreement or
understanding, directly or indirectly, with any person to distribute the securities. 

 The Company is required to pay certain fees and expenses incurred by the Company incident to
the registration of the securities; provided, however, that each Selling Stockholder will pay all underwriting discounts and selling commissions, if any, and any related legal expenses incurred by it. The Company has agreed to
indemnify the Selling Stockholders against certain losses, claims, damages and liabilities, including liabilities under the Securities Act. The Company may be indemnified by the Selling Stockholders against civil liabilities, including liabilities
under the Securities Act, that may arise from any written information furnished to the Company by the Selling Stockholders specifically for use in this prospectus in accordance with the related Registration Rights Agreement, or the Company may be
entitled to contribution. 
 We agreed to keep this prospectus effective until the earlier of (i) the date on which the securities may
be resold by the Selling Stockholders without registration and without regard to any volume or manner-of-sale limitations by reason of Rule 144, without the requirement
for the Company to be in compliance with the current public information requirement under Rule 144 under the Securities Act or any other rule of similar effect or (ii) the date on which all of the securities have been sold pursuant to this
prospectus or Rule 144 under the Securities Act or any other rule of similar effect. The resale securities will be sold only through registered or licensed brokers or dealers if required under applicable state securities laws. In addition, in
certain states, the resale securities covered hereby may not be sold unless they have been registered or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is complied with.

 Under applicable rules and regulations under the Exchange Act, any person engaged in the distribution of the resale securities may not
simultaneously engage in market making activities with respect to the ordinary shares for the applicable restricted period, as defined in Regulation M, prior to the commencement of the distribution. In addition, the Selling Stockholders will be
subject to applicable provisions of the Exchange Act and the rules and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of the ordinary shares by the Selling Stockholders or any other person. We will
make copies of this prospectus available to the Selling Stockholders and have informed them of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including by compliance with Rule 172 under the
Securities Act). 

 Annex B 

Selling Stockholder Notice and Questionnaire 

The undersigned beneficial owner of ordinary shares, including in the form of American Depositary Shares, and/or ordinary shares acquirable
upon exercise of certain outstanding warrants (the “Registrable Securities”) of DBV Technologies S.A., a société anonyme organized under the laws of the French Republic (the “Company”), understands
that the Company has filed or intends to file with the Securities and Exchange Commission (the “Commission”) a registration statement (the “Registration Statement”) for the registration and resale under Rule 415 of
the Securities Act of 1933, as amended (the “Securities Act”), of the Registrable Securities, in accordance with the terms of the Registration Rights Agreement (the “Registration Rights Agreement”) to which this
document is annexed. A copy of the Registration Rights Agreement is available from the Company upon request at the address set forth below. All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the
Registration Rights Agreement. 
 Certain legal consequences arise from being named as a selling stockholder in the Registration Statement
and the related prospectus. Accordingly, holders and beneficial owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or not being named as a selling stockholder in the
Registration Statement and the related prospectus. 
 NOTICE 

The undersigned beneficial owner (the “Selling Stockholder”) of Registrable Securities hereby elects to include the
Registrable Securities owned by it in the Registration Statement. 
 QUESTIONNAIRE 

The undersigned hereby provides the following information to the Company and represents and warrants that such information is accurate: 

 

	1.	 Name. 

(a)       Full Legal Name of Selling Stockholder: 

 

                       
                                         
                                         
                                         
                                         
                      
 (b)
      Full Legal Name of Registered Holder (if not the same as (a) above) through which Registrable Securities are held: 
  

                       
                                         
                                         
                                         
                                         
                      
 (c)
      Full Legal Name of Natural Control Person (which means a natural person who directly or indirectly alone or with others has power to vote or dispose of the securities covered by this Questionnaire): 

 

                       
                                         
                                         
                                         
                                         
                      
  

	2.	 Address for Notices to Selling Stockholder: 

 

                       
                                         
                                         
                                         
                                         
                      
  

                       
                                         
                                         
                                         
                                         
                      

Telephone:
                                         
                                        

Fax:
                                         
                                         
         
 Contact
Person:                                        
                                         
                                         
                                         
                    

	3.	 Broker-Dealer Status: 

(a) Are you a broker-dealer? 
 Yes
☐ No ☐ 
 (b) If “yes” to Section 3(a), did you receive your Registrable Securities as compensation for
investment banking services to the Company? 
 Yes ☐ No ☐ 

Note: If “no” to Section 3(b), the Commission’s staff has indicated that you should be identified as an underwriter in the
Registration Statement. 
 (c) Are you an affiliate of a broker-dealer? 

Yes ☐ No ☐ 
 (d) If
you are an affiliate of a broker-dealer, do you certify that you purchased the Registrable Securities in the ordinary course of business, and at the time of the purchase of the Registrable Securities to be resold, you had no agreements or
understandings, directly or indirectly, with any person to distribute the Registrable Securities? 
 Yes ☐ No ☐ 

Note: If “no” to Section 3(d), the Commission’s staff has indicated that you should be identified as an underwriter in the
Registration Statement. 
  

	4.	 Beneficial Ownership of Securities of the Company Owned by the Selling Stockholder.

 Except as set forth below in this Item 4, the undersigned is not the beneficial or registered owner of any
securities of the Company other than the securities issuable pursuant to the Purchase Agreement. 
 (a) Type and Amount of other securities
beneficially owned by the Selling Stockholder: 
  

                          
                                         
                                         
                                         
                                         
                           
  

                          
                                         
                                         
                                         
                                         
                           
  

	5.	 Relationships with the Company: 

Except as set forth below, neither the undersigned nor any of its affiliates, officers, directors or principal equity holders (owners of 5% of
more of the equity securities of the undersigned) has held any position or office or has had any other material relationship with the Company (or its predecessors or affiliates) during the past three years. 

State any exceptions here: 
  

                          
                                         
                                         
                                         
                                         
                           
  

                          
                                         
                                         
                                         
                                         
                           

 The undersigned agrees to promptly notify the Company of any material inaccuracies or
changes in the information provided herein that may occur subsequent to the date hereof at any time while the Registration Statement remains effective; provided, that the undersigned shall not be required to notify the Company of any changes to the
number of securities held or owned by the undersigned or its affiliates. 
 By signing below, the undersigned consents to the disclosure of
the information contained herein in its answers to Items 1 through 5 and the inclusion of such information in the Registration Statement and the related prospectus and any amendments or supplements thereto. The undersigned understands that such
information will be relied upon by the Company in connection with the preparation or amendment of the Registration Statement and the related prospectus and any amendments or supplements thereto. 

IN WITNESS WHEREOF the undersigned, by authority duly given, has caused this Notice and Questionnaire to be executed and delivered either in
person or by its duly authorized agent. 
  

									
		 		 		 	Beneficial Owner:
	Date:	 	 	 		 	 
					
		 		 		 	By:	 	 
		 		 		 	Name:	 	
		 		 		 	Title:	 	

 PLEASE EMAIL A PDF COPY OF THE COMPLETED AND EXECUTED NOTICE AND QUESTIONNAIRE TO:EX-10.13

 Exhibit 10.13 

EXECUTION VERSION 

CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE 

EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE 

REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. SUCH EXCLUDED 

INFORMATION HAS BEEN MARKED WITH “[***].” 

DATA SERVICES AND LICENSE AGREEMENT 
 This
cover sheet (the “Cover Sheet”), together with the Terms and Conditions attached as Attachment A (the “Terms”) and any other exhibits or attachments, constitute the Data Services and License
Agreement (the “Agreement”), effective as of January 26, 2022 (the “Effective Date”), by and between Life360, Inc., a Delaware corporation (“Life360”), and Placer Labs
Inc., a Delaware corporation (“Placer”). Each of Life360 and Placer is a “Party” or a “party,” and collectively the “Parties” or
“parties.” 
  

			
	Placer
		
	Complete Entity Name:	  	Placer Labs Inc.
		
	Principal Place of Business:	  	340 Lemon Avenue #1277, Walnut, CA 91789
		
	Contact Name:	  	[***]
		
	Contact Email:	  	[***]
		
	Privacy Policy URL:	  	https://www.placer.ai/privacy-policy/
	
	Life360
		
	Complete Entity Name:	  	Life360 Inc.
		
	Principal Place of Business:	  	539 Bryant Street, Suite 402, San Francisco CA 94107
		
	Contact Name:	  	Kirsten Daru
		
	Contact Email:	  	[***]
		
	Privacy Policy URL:	  	https://support.life360.com/hc/en-us/articles/360043228154
	
	Services Details
		
	Data Processing Services Provided by Placer	  	Subject to, and as described in, the Agreement and in partial consideration of the Placer Fees (as defined below), Placer shall perform the following data processing services for Life360 pursuant to Life360’s reasonable
instructions consistent with the Agreement and the Agreement and on Life360’s behalf (collectively, the “Placer Data Processing Services”):

 EXECUTION VERSION 

 

			
		  	 •  Differential Privacy Service. [***] as further described in the second
column of Attachment C-1. Placer will provide support, bug fixes and other maintenance in accordance with the Attachments.
  

•  Filtering and Analytics Service. [***] as described in Section 2 of Attachment A
which Placer shall deliver to Life360.

		
	Additional Services Provided by Placer	  	 Subject to, and as described in, the Agreement and in partial consideration of the Placer Fees, Placer shall provide the following services
to Life360:
  
 •  POI
Data (as per Attachment E) – Placer will grant Life360 a license [***] as further specified in the Agreement.
  

•  Placer Analytics (as per Attachment F) – Life360 will be granted a license from
Placer to [***].

		
	Aggregated Data	  	Subject to, and as described in, the Agreement and in consideration of the Life360 Fees, Placer may freely use and otherwise process, including sell, Aggregated Data, subject to the limitations and restrictions set forth in the
Agreement.
		
	Fees:	  	 Fees payable by Life360
  

Life360 shall pay Placer the fees as set forth in Attachment D (the “Placer Fees”).

		
		  	 Fees payable by Placer
  

Placer shall pay Life360 the fees as set forth in Attachment D (the “Life360 Fees”).

 The above in this “License Details” section is a summary of the operative and binding terms located in the below
Attachments. In the event of a conflict between the “License Details” and the below Attachments, the Attachments will govern. 

 EXECUTION VERSION 

 

 Execution 

In consideration of the mutual promises and covenants in the Agreement, each party has caused this Agreement to be executed by a duly authorized
representative as of the Effective Date. By executing this Agreement, each party affirms that it fully understands and accepts all applicable terms, policies and conditions of this Agreement, and enters into the same with the other party. 

 

									
	LIFE360, INC.	  	                                	  	PLACER
					
	By:	  	/s/ Chris Hulls	  		  	By:	  	/s/ Noam Ben-Zvi
		  	(sign)	  		  		  	(sign)
					
	Name:	  	Chris Hulls	  		  	Name:	  	Noam Ben-Zvi
		  	(print)	  		  		  	(print)
					
	Title:	  	CEO	  		  	Title:	  	CEO
		  	(print)	  		  		  	(print)

  

 EXECUTION VERSION 

 

 ATTACHMENT A 

Terms and Conditions 
  

	1.	 Definitions: 

  

	 	a.	 “Aggregated Data” means [***]. 

 

	 	b.	 “Anonymized Data” means [***]. 

 

	 	c.	 “Daily Active User” or “DAU” means [***].

  

	 	d.	 “Data Types” are set forth in Attachment B. 

 

	 	e.	 “DPS Input” means [***]. 

 

	 	f.	 “DPS Output” means [***]. 

 

	 	g.	 “Expenses” means actual out-of-pocket expenses [***] with respect exclusively to setting up and operating the DPS, including but not limited to expenses associated with and/or related to [***], provided that Life360 obtains
Placer’s written approval of the categories of expenses it will be expected to be responsible for before any such expenses are incurred, which shall not be unreasonably withheld. [***] 

 

	 	h.	 [***]. 

  

	 	i.	 [***]. 

  

	 	j.	 “Life360 Data” means [***]. 

 

	 	k.	 “Life360 Property” means, collectively, any data or other intellectual property
(e.g., [***]) created, processed or developed by Life360 as well as Life360 Data. Life360 Property is owned by Life360. 

  

	 	l.	 “Placer Property” means, collectively, all Placer products and services [***] as
well as intellectual property rights in the foregoing. Placer Property is owned by Placer. 

  

	 	m.	 “Placer Analytics Platform” means Placer’s Physical-World Analytics
Platform, Placer software code and any work product, reports, or other output or results, designs, methods, inventions, know- how, techniques, applications, or other materials or technology, or any enhancements to the foregoing.

  

	 	n.	 [***]. 

  

	 	o.	 “Placer Provided Aggregated Data” has the meaning set forth in Attachment F.

  
 4 

 EXECUTION VERSION 

 

	2.	 Placer Data Services 

 

	 	a.	 Privacy Focused DPS and Suspension. Life360 and Placer acknowledge and agree that Life360
shall license [***] (the “Differential Privacy Service” or “DPS”) as described herein and in Attachment C. Each of Life360 and Placer agrees to comply with its obligations and perform the
services, as applicable, as set forth in Attachment C. 

 [***] 

 

	 	b.	 Life360 Data Provided to Placer for the Data Processing Services. [***].

  

	 	i.	 [***]. 

  

	 	ii.	 [***]. 

  

	 	iii.	 [***]. 

  

	 	iv.	 [***] . 

  

	 	c.	 [***]. 

  

	 	i.	 [***]. 

  

	 	d.	 [***]. 

  

	 	i.	 [***]. 

  

	 	ii.	 [***]. 

  

	 	iii.	 [***]. 

  

	 	iv.	 [***]. 

  

	 	e.	 [***]. 

  

	 	f.	 [***]. 

  

	 	i.	 [***]. 

  

	 	g.	 Placer shall have the right to update and modify the DPS software at its sole discretion, so long as it
preserves at least substantially the same amount of privacy measures as set forth in Attachment C-1. Placer will (i) assist Life360 with setting up the DPS and (ii) perform any maintenance,
bug fixes, or similar updates to the DPS as reasonably requested by Life360. [***]. 

  

	 	h.	 [***]. 

  
 5 

 EXECUTION VERSION 

 

	3.	 Placer License, Restrictions and Obligations 

 

	 	a.	 License and Restrictions. Sole and exclusive title to and ownership of the (i) Placer
Property, and (ii) all trade secrets, know-how, inventions, techniques, processes, algorithms, software programs, schematics, documentation related thereto created or owned by, or provided to Life360 by,
Placer (collectively, “Placer Information”), including, without limitation, all derivatives, improvements, developments, enhancements and modifications thereof made during, after, in connection with or as a result of this
Agreement, shall at all times remain with Placer. For the avoidance of doubt, Placer Property is proprietary to Placer and Placer owns all intellectual property rights in and with respect to all Placer Property. Subject to the terms and conditions
of this Agreement, Placer hereby grants to Life360 a non-transferable and non-assignable (except in accordance with Section 13.b below), non-exclusive, limited license, without the right to sub- license (except to its contractors performing services on its behalf), to use Placer Property provided to or made
available to Life360 for the sole purposes of exercising rights and performing obligations set forth herein. For clarity, with respect to the contractors mentioned in the foregoing parenthesis, Life360 shall ensure that such contractors comply with
all of Life360’s obligations and restrictions under this Agreement, and Life360 shall be liable for any non-compliance by such contractors as if they were Life360’s own
non-compliance. 

 Except as expressly set forth under this Agreement, no license,
expressed or implied, in the Placer Property or Placer Information is granted hereunder and Life360 shall not (i) create derivative works, modify, analyze source code, reverse engineer, decompile or disassemble or otherwise determine the source
code or inner functionality of any Placer Property or component thereof; (ii) utilize any computer software or hardware which is designed to defeat any copy protection of the Placer Property; (iii) copy the
look-and-feel of Placer Property; (iv) remove any proprietary notices, marks, labels, or logos from the Placer Property and shall not permit others to do so; or
(v) use the Placer Property or Placer Information for any other purpose not expressly permitted in this Agreement. Life360 may provide feedback (“Feedback”) to Placer in respect of the Placer Property. Placer has not
agreed and does not agree to treat as confidential any Feedback provided by Life360 with respect to the Placer Property, and nothing in this Agreement or in the parties’ dealings arising out of or related to this Agreement will restrict
Placer’s right to use, profit from, disclose, publish, or otherwise exploit any Feedback, without compensating Life360, provided that Placer does not identify Life360 as the provider of any Feedback. Without limiting the generality of the
foregoing, Life360 agrees that its provision of Feedback does not give it any intellectual property or any other right, title, or interest in or to any software, inventions, or other assets created by Placer, even if such Feedback leads Placer to
create the software, invention, or other asset. Nothing in this Agreement will limit any of Life360’s rights under applicable law or prohibit Life360 from developing products, branding, concepts, systems or techniques that are similar to or
compete with the DPS provided that Life360 does not violate any of its obligations under this Agreement in connection with such development. The Parties shall comply with the obligations and perform the services set forth in
Attachment C. 

  
 6 

 EXECUTION VERSION 

 

	 	b.	 [***]. 

  

	 	i.	 [***]. 

  

	 	c.	 Placer Obligations 

 

	 	i.	 [***]. 

  

	 	ii.	 [***]. 

  

	 	A.	 [***]. 

  

	 	B.	 [***]. 

  

	 	C.	 [***]. 

  

	 	iii.	 [***]. 

  

	 	iv.	 [***]. 

  

	 	v.	 [***]. 

  

	 	d.	 Exclusivity. During the Term and for the period thereafter (if any) set forth in Section 6.d,
notwithstanding anything to the contrary herein and otherwise consistent with the terms of Schedule H, Life360 and its Affiliates shall not sell, license, deliver, make available, or otherwise provide or grant any rights to any third party or
person, or permit any third party or person to receive, purchase, have access to, use, or otherwise process [***] “Restricted Data”), [***]. 

 

	 	i.	 Delivery. Subject to and conditioned on Placer’s payment of fees and Expenses (as applicable) set
forth in this Agreement and Placer’s and its Authorized Users’ compliance with the terms and conditions of this Agreement and the Delivery and Information Security Terms attached as Attachment G, during the applicable period during the
Term, Life360 will provide Placer access to DPS Output in the form and for the purposes specified herein in accordance with the following: 

  

	 	ii.	 [***]. 

  

	 	iii.	 [***] 

  

	4.	 Compliance Obligations and Privacy Focused Practices 

 

	 	a.	 Legal Compliance. [***]. 

 

	 	b.	 Other Obligations. 

 

	 	i.	 [***]. 

  
 7 

 EXECUTION VERSION 

 

	 	ii.	 [***] 

  

	 	iii.	 [***] 

  

	 	iv.	 [***] 

  

	 	c.	 Life360 Records and Audit. [***] 

 

	 	d.	 Placer Records and Audit. [***] 

 

	5.	 Payments 

  

	 	a.	 Payments. 

  

	 	i.	 Placer will pay Life360 fees in accordance with Attachment D herein. Throughout the Term and to the extent
consistent with Attachment D herein, Placer will calculate the Life360 Fees owed in accordance with this Agreement on a calendar monthly basis. Within 15 days of the end of each calendar month during which fees were incurred, Placer shall provide a
report (the “Life360 Fee Report”) that details the actual Life360 Fees calculation. Life360 will then invoice Placer, and Placer will pay the Life360 Fees within thirty (30) days of Placer’s receipt of the invoice.
If Placer fails to send the Life360 Fee Report within 15 days of the end of each calendar month, Life360, in its sole discretion, will calculate the fees owed in a manner consistent with this Agreement, and such amount shall be paid no later than
twenty (20) days following Placer’s receipt of the invoice. Placer will further pay Expenses due to Life360 within thirty (30) days of receiving an invoice and statement of Expenses from Life360. If this Agreement is terminated, all
undisputed Fees and Expenses due at the time of termination shall be paid within thirty (30) days of the effective date of termination. Placer shall pay taxes, fees, and similar governmental charges, if any, the amount of which must be set
forth in the Cover Sheet, related to the execution or performance of this Agreement, other than taxes on Life360’s net income. Should Placer fail to pay Life360 Fees by the deadlines set forth herein, and fail to cure within seven
(7) calendar days after receiving written notice from Life360 of such missed deadline, Life360 shall have the immediate right to terminate this Agreement, in addition to all rights and remedies available to it under the law and this Agreement.

  

	 	ii.	 Life360 will pay the Placer Fees owed in accordance with this Agreement on a calendar monthly basis, with
payment to made within thirty (30) days of the end of each calendar month. 

  

	 	iii.	 All amounts due under this Agreement are denominated in, and shall be paid in, U.S. Dollars.

  
 8 

 EXECUTION VERSION 

 

	 	iv.	 Within seven (7) business days of issuing an invoice to which Placer is entitled to a credit under
Attachment H, Life360 will issue a credit memo to Placer. 

  

	 	v.	 The parties will use commercially reasonable efforts to expeditiously resolve any disputes concerning amounts
due pursuant to this Section 5. 

  

	 	b.	 Audits. Audits may be performed, and shall be at Life360’s sole expense, except as set forth below.
Any audit shall be performed by an independent auditor not compensated on a contingency-fee basis (the “Auditor”) and shall be subject to the terms of a confidentiality agreement
reasonably acceptable to Placer. Any information made available, known and/or acquired during the course of such audit shall be treated as Confidential Information that is proprietary to Placer and subject to the confidentiality obligations under
this Agreement. If, as a result of such audit, Life360 discovers an error of more than the Threshold Amount, Placer will reimburse Life360 for the expenses of the Auditor. “Threshold Amount” means the greater of (A) [***] or
(B) [***] for the relevant period. 

  

	6.	 Term and Termination 

 

	 	a.	 Term. This Agreement shall start on the Effective Date and continue for a period of three (3) years
following the Fully Exclusive Date (as defined in Attachment D) (the “Initial Term”) unless earlier terminated as provided herein, and shall automatically renew for successive one (1) year terms (each, a
“Renewal Term”) solely in the event that either party gives written notice of such party’s intent to renew (“Renewal Notice”) at least [***] days prior to the start of any Renewal Term and the
recipient of such Renewal Notice either: 

  

	 	(A)	 by written notice confirms the renewal, or 

 

	 	(B)	 does not by written notice to the other party indicate its intent not to renew within [***] days of receipt of
a Renewal Notice. 

 (the foregoing period shall be referred to as the “Term”). For clarity,
during said [***] day period, (i) so long as the recipient of the Renewal Notice has not by written notice confirmed the renewal, the party that provided the Renewal Notice can withdraw the Renewal Notice immediately at any time; and
(ii) if the other party rejects such Renewal Notice, the Agreement shall expire at the end of the Term. 
  

	 	b.	 Termination. Neither party may terminate this Agreement for convenience. Except as otherwise set forth
herein, either party may terminate this Agreement effective immediately if the other party is in material breach of any obligation, representation or warranty under this Agreement and fails to cure such material breach (if capable of cure) within
forty-five (45) days after receiving written notice specifying the nature of the breach from the non-breaching party (any such termination, a “Termination for Breach”). Either
party may immediately terminate this Agreement upon written notice at any time if (i) the other party files 

  
 9 

 EXECUTION VERSION 

 

	 	
a petition for bankruptcy or is adjudicated as bankrupt, (ii) a petition in bankruptcy is filed against the other party and such petition is not removed or resolved within sixty
(60) calendar days, (iii) the other party makes an assignment for the benefit of its creditors or an arrangement for its creditors pursuant to bankruptcy law, (iv) the other party discontinues its business, (v) a receiver is
appointed over all or substantially all of the other party’s assets or business, or (vi) the other party is dissolved or liquidated or otherwise ceases to function as a going concern (any such termination, a “Solvency
Termination”). Each party, as applicable, may terminate this Agreement by [***] (as defined in Attachment D). 

  

	 	c.	 [***]. 

  

	 	i.	 [***] 

  

	 	ii.	 [***] 

  

	 	iii.	 [***] 

  

	 	iv.	 If Life360 terminates this Agreement pursuant to Section 2.d.iii or Section 6.c.i, and such
termination is not a Permitted Termination, then: (A) if such termination takes effect prior to the first anniversary of the Fully Exclusive Date, then Life360 shall promptly pay Placer an early termination fee equal to ten million dollars
($10,000,000); and (B) if such termination takes place at any time thereafter, then Life360 shall promptly pay Placer an early termination fee equal to five million dollars ($5,000,000). 

 

	 	d.	 Effect of Termination. In the event that this Agreement expires or is terminated for any reason,
Sections [***], together with the relevant portions of the Attachments shall survive expiration or termination of this Agreement. [***], in the event of the termination of this Agreement, Section 3.d shall survive until the earlier of:
(i) the date on which the Initial Term or the then-current Renewal Term would have ended absent the early termination of this Agreement; and (ii) the date on which Life360 terminates the Agreement pursuant to Section 6.b for
Placer’s uncured material breach or a Solvency Termination by Life360. Any termination of this Agreement other than a Permitted Termination, [***] shall be deemed a “Premature Termination”. 

 

	 	e.	 Willful Refusal or Frustration. The following, each a “Willful Refusal,” are
hereby deemed a material breach of this Agreement: [***]. 

  

	7.	 Representations and Warranties and Covenants 

 

	 	a.	 Each party represents, warrants and covenants to the other party that (a) it has the full power and
authority to enter into and perform fully this Agreement, (b) the execution of this Agreement and the performance of its obligations under this Agreement do not violate any other agreement to which it is a party, and (c) the person signing
this Agreement on such party’s behalf has been duly authorized and empowered to enter into this Agreement and this Agreement constitutes a legal, valid and binding obligation when executed and delivered. Each party shall comply with all
applicable Laws, and shall at its sole expense obtain and maintain the governmental authorizations, registrations and filings required by any jurisdiction in connection with the execution or performance of this Agreement. 

  
 10 

 EXECUTION VERSION 

 

	 	b.	 Life360 represents, warrants and covenants to Placer that it has, and will continue to have, all rights
to Life360 Data needed to perform its obligations and to grant Placer the rights granted under this Agreement; and to Life360’s knowledge, Life360 Data is free of infection from any viruses or other code or computer programming routines that
contain contaminating or destructive properties or that will damage, surreptitiously intercept or expropriate any system, data or information. Further, Life360 represents, warrants and covenants that: 

 

	 	i.	 [***]. 

  

	 	ii.	 [***] 

  

	 	iii.	 [***] 

  

	 	c.	 Placer represents, warrants and covenants that: 

 

	 	i.	 [***] 

  

	 	ii.	 [***] 

  

	8.	 Confidentiality 

 

	 	a.	 Definition. “Confidential Information” means any and all information that is
disclosed by either party to the other party, either directly or indirectly, in writing, orally or by inspection of tangible objects, that if disclosed in writing or tangible form is marked as “Confidential” or with some similar
designation, or if disclosed orally, is identified as being proprietary and/or confidential at the time of disclosure, or that under the circumstances and nature of the information should reasonably deemed to be confidential (including without
limitation the existence and terms of this Agreement, which is Confidential Information of both parties). Without limiting the foregoing and regardless of whether identified as being proprietary and/or confidential, Confidential Information of
Life360 includes without limitation Life360 Data. 

  

	 	b.	 Use and Disclosure Restrictions. Each party shall not use the other party’s Confidential
Information except as necessary to exercise its rights or perform its obligations under this Agreement, or as expressly permitted by this Agreement. Each party shall not disclose the other party’s Confidential Information to any third party,
and shall only disclose such Confidential Information to those of its employees, contractors and agents that need to know such Confidential Information for the purposes of this Agreement, provided that each such employee, contractor or agent is
subject to a written agreement that includes binding use and disclosure restrictions that are at least as protective of Confidential Information as those set 

  
 11 

 EXECUTION VERSION 

 

	 	
forth in this Agreement. Each party will use all reasonable efforts to maintain the confidentiality of all Confidential Information of the other party in its possession or control, but in no
event less than reasonable care. The foregoing obligations will not restrict either party from disclosing Confidential Information of the other party (i) pursuant to the order or requirement of a court, administrative agency, or other
governmental body, provided that the party required to make such a disclosure gives reasonable notice to the other party to contest such order or requirement and cooperates with the disclosing party, at the disclosing party’s request and
expense, in any lawful action to contest or limit the scope of such required disclosure or (ii) on an as-needed, confidential basis to its legal or financial advisors. Without limiting the restrictions
set forth in Section 2, the foregoing obligations will not apply to any information that the receiving party can demonstrate with competent evidence (i) is or becomes generally known to the public through no fault of or breach of this
Agreement by the receiving party, (ii) was rightfully known by the receiving party at the time of disclosure without an obligation of confidentiality as shown by the contemporaneous records of the receiving party, (iii) is independently
developed by the receiving party without use of, reference, or access to the disclosing party’s Confidential Information as shown by the written records of the receiving party, or (iv) the receiving party rightfully obtains from a third
party that had the right to make such disclosure without an obligation of confidentiality. 

  

	 	c.	 [***] 

  

	 	d.	 Return of Confidential Information. The receiving party will return to the disclosing party or destroy
all Confidential Information of the disclosing party in the receiving party’s possession or control and permanently erase all electronic copies of such Confidential Information promptly upon the written request of the disclosing party or upon
the expiration or termination of the Agreement. Upon request of the disclosing party, the receiving party will certify in writing signed by an officer of the receiving party that it has fully complied with its obligations under this
Section 8.d. 

  

	 	e.	 Injunctive Relief. The parties agree that any breach of this Section 8 will cause irreparable harm
to the disclosing party for which monetary damages will be inadequate. Accordingly, the disclosing party will be entitled to seek and, if granted, obtain and enforce injunctive or other equitable relief (in addition to any other remedies available
to it) to remedy any threatened or actual breach of this Section 8. 

  

	 	f.	 Confidential Treatment Request. If either party is required to file or disclose this Agreement or any
portion thereof with the United States Securities and Exchange Commission (the “SEC”) or any other governmental authority (whether in the U.S. or otherwise), Life360 will give Placer advance notice and an opportunity to
comment on the materials being disclosed. Each party shall use its commercially reasonable efforts to procure confidential treatment of the Agreement or relevant provisions thereof pursuant to the Securities Act of 1933 or the Securities Exchange
Act of 1934 (or foreign equivalent), in each case as amended, and the rules, regulations and guidelines promulgated thereunder, or any laws and regulations (whether in the U.S. or otherwise). Each party shall use its commercially reasonable efforts
to procure confidential treatment for such portions of the Agreement as may be reasonably requested in a timely manner by the other party. 

  
 12 

 EXECUTION VERSION 

 

	 	g.	 Notwithstanding anything to the contrary in this Agreement, nothing in this Section 8 restricts
rights otherwise granted under this Agreement. 

  

	9.	 Indemnification 

 

	 	a.	 Indemnification by Life360. Life360 shall indemnify, defend and hold Placer and its directors, officers,
employees and Affiliates (each an “Placer Indemnified Party”) harmless from and against any damages, losses, liabilities, judgments, costs and expenses (including reasonable attorneys’ fees) arising out of or relating to
any third-party claim or action arising from [***]. As used in this Agreement, “Affiliate” means, as to any entity, any other entity directly or indirectly controlling, controlled by, or under common control with, such
entity. 

  

	 	b.	 Procedure for Indemnification by Life360. Placer shall (i) promptly notify Life360 in writing of
any claim implicating the foregoing indemnification obligations, (ii) grant Life360 sole control of the defense and/or settlement of the claim, provided, however, that Life360 must not settle any claim that does not unconditionally release
Placer or that imposes non-monetary obligations, without Placer’s prior written consent, and (iii) provide Life360, at Life360’s expense, with all assistance, information and authority
reasonably required for the defense and/or settlement of the claim. Placer may at its election and expense participate in the defense of any action. 

  

	 	c.	 Indemnification by Placer. Placer shall indemnify, defend and hold Life360 and its directors, officers,
employees and Affiliates (each a “Life360 Indemnified Party”) harmless from and against any damages, losses, liabilities, judgments, costs and expenses (including reasonable attorneys’ fees) arising out of or relating to
any third-party claim or action arising from [***]. 

  

	 	d.	 Procedure for Indemnification by Placer. Life360 shall (i) promptly notify Placer in writing of any
claim implicating the foregoing indemnification obligations, (ii) grant Placer sole control of the defense and/or settlement of the claim, provided, however, that Placer must not settle any claim that does not unconditionally release Life360 or
that imposes non-monetary obligations, without Life360’s prior written consent, and (iii) provide Placer, at Placer’s expense, with all assistance, information and authority reasonably required
for the defense and/or settlement of the claim. Life360 may at its election and expense participate in the defense of any action. 

  
 13 

 EXECUTION VERSION 

 

	10.	 Disclaimers and Limitation of Liability 

 

	 	a.	 Disclaimers. EXCEPT AS EXPRESSLY SET FORTH IN THIS AGREEMENT, EACH PARTY HEREBY DISCLAIMS ALL
REPRESENTATIONS AND WARRANTIES REGARDING THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY, INCLUDING ANY IMPLIED WARRANTIES OF MERCHANTABILITY, NONINFRINGEMENT, TITLE, FITNESS FOR A PARTICULAR PURPOSE, AND IMPLIED WARRANTIES ARISING FROM
COURSE OF DEALING OR PERFORMANCE. EACH PARTY ACKNOWLEDGES THAT IT HAS RELIED ON NO REPRESENTATIONS OR WARRANTIES OTHER THAN THE EXPRESS WARRANTIES IN THIS AGREEMENT. 

 

	 	b.	 Limitation of Liability. EXCEPT FOR A PARTY’S CONFIDENTIALITY OR INDEMNIFICATION OBLIGATIONS UNDER
THIS AGREEMENT, OR BREACH THEROF, FRAUD OR WILLFUL MISCONDUCT, LIQUIDATED DAMAGES DUE UNDER THIS AGREEMENT, A WILLFUL REFUSAL OFEITHER PARTY, OR A PARTY’S WRONGFUL TERMINATION OF THE AGREEMENT, IN NO EVENT WILL EITHER PARTY BE LIABLE FOR ANY
CONSEQUENTIAL, INDIRECT, EXEMPLARY, SPECIAL OR INCIDENTAL DAMAGES, INCLUDING WITHOUT LIMITATION ANY DAMAGES RELATING TO LOST DATA AND/OR LOST PROFITS, ARISING FROM OR RELATING TO THE THIS AGREEMENT, REGARDLESS OF THE FORM OF ACTION, WHETHER IN
CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY WAS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. EXCEPT FOR A PARTY’S INDEMNIFICATION OBLIGATIONS UNDER THIS AGREEMENT, OR BREACH THEROF, FRAUD OR WILLFUL MISCONDUCT, LIQUIDATED DAMAGES DUE UNDER
THIS AGREEMENT, A WILLFUL REFUSAL OFEITHER PARTY, OR A PARTY’S WRONGFUL TERMINATION OF THE AGREEMENT, EACH PARTY’S TOTAL CUMULATIVE LIABILITY IN CONNECTION WITH THIS AGREEMENT (INCLUDING WITH RESPECT TO THE LIQUIDATED DAMAGES DUE UNDER
THIS AGREEMENT) SHALL NOT EXCEED AN AMOUNTS PAID OR PAYABLE IN THE TWELVE MONTHS PRECEDING THE CIRCUMSTANCES THAT GAVE RISE TO THE CLAIM AT ISSUE OR IF DURNG THE FIRST YEAR FOLLOWING THE EFFECTIVE DATE $20 MILLION. THE EXISTENCE OF MORE THAN ONE
CLAIM SHALL NOT ENLARGE THIS AMOUNT. THE LIMITATION OF LIABILITY SET FORTH IN THIS SECTION WILL APPLY EVEN IF ANY LIMITED REMEDY SPECIFIED IN THIS AGREEMENT IS FOUND TO HAVE FAILED OF ITS ESSENTIAL PURPOSE. EACH PARTY ACKNOWLEDGES AND AGREES THAT
THIS SECTION 10.b IS AN ESSENTIAL ELEMENT OF THE AGREEMENT AND THAT, IN ITS ABSENCE, THE ECONOMIC TERMS OF THIS AGREEMENT WOULD BE SUBSTANTIALLY DIFFERENT. 

  

	11.	 Ownership. Subject to the rights expressly granted pursuant to this Agreement, as between Life360
and Placer: (a) Life360 owns all right, title, and interest in and to (i) the Life360 Property, [***]; and (b) Placer owns all right, title and interest in and to (i) the Placer Property, [***] . 

  
 14 

 EXECUTION VERSION 

 

	12.	 Marketing. Joint press releases or other communications must be mutually approved in advance by
Life360 and Placer. Unilateral references or other non-press related communications by a party such as social media, newsletters, websites, presentations, blogs and other methods that may be relevant from time
to time, in which the other party’s name and/or logo appears, shall require the other party’s prior written consent which shall not be unreasonably withheld. Notwithstanding any other provisions, Life360 shall not use any trade name,
trademark, service mark, logo, commercial symbol, or any other proprietary rights of Placer or any of its Affiliates in any manner (including any use in press release, advertisement, or any other marketing, promotional, or publicly available
materials) without specific prior written authorization of each instance of such use by an officer of Placer with a title of Vice President or higher unless compelled by applicable law. 

 

	13.	 Miscellaneous. 

 

	 	a.	 Relationship of the Parties. The parties are independent contractors with respect to one other. This
Agreement does not create and shall not be construed as creating a partnership, joint venture, or employment relationship between the parties. Neither party shall have, and shall not represent to any third party that it has, any right to obligate or
bind the other party in any manner whatsoever. Nothing in this Agreement shall give, or is intended to give, any rights of any kind to any third party. 

  

	 	b.	 Assignment. Neither party may transfer or assign to any third party any of its rights or obligations
under this Agreement (and, in the case of Placer as assignor, any Life360 Data), whether by operation of law or otherwise, without the prior express written consent of the other party (not to be unreasonably withheld). Each party shall notify the
other party in writing at least fifteen (15) days prior to undergoing a merger, acquisition, change of Control, or sale of all or substantially all of its assets or business to which this Agreement relates (collectively, a “Change of
Control”). If either Party notifies the other Party that it will undergo a Change of Control to a successor that the party not undergoing the Change of Control reasonably believes in good faith, based on the past conduct of such entity,
(i) would be likely to materially, and intentionally or as a result of gross negligence, misuse or mishandle the Life360 Data or Placer Property; (ii) is a bona fide competitor of the party not undergoing the Change of Control; or
(iii) that the Change of Control would have a material and detrimental impact on the reputation of the party not undergoing the Change of Control, then, in each case of (i) through (iii), the party not undergoing the Change of Control may
terminate this Agreement by giving written notice of termination to the party undergoing the Change of Control within thirty (30) days after receiving the notification described in the immediately foregoing sentence. This Agreement otherwise
inures to the benefit of and shall be binding on the parties’ permitted assignees, transferees and successors. For the purposes of this Section 13.b, “Control” means, with respect to an entity: (1) to possess,
directly or indirectly, the power to direct affirmatively the management and policies of such entity, whether through ownership of voting securities or by contract relating to voting rights or corporate governance; or (2) ownership of more than
50% of the voting securities in such entity. A termination pursuant to the immediately foregoing sentence shall be deemed a Permitted Termination. For the avoidance of doubt, a reorganization or assignment to an Affiliate shall not be deemed a
Change of Control. 

  
 15 

 EXECUTION VERSION 

 

	 	c.	 Waiver. A waiver of any provision of this Agreement will only be valid if provided in writing and will
only be applicable to the specific instance and occurrence so waived. The failure by either party to insist upon the strict performance of this Agreement, or to exercise any term hereof, will not act as a waiver of any right, promise or term herein.
Any delay in the performance of any duties or obligations of either party (except the payment of money owed) will not be considered a breach of this Agreement if such delay is caused by a labor dispute, shortage of materials, fire, earthquake,
flood, or any other event beyond the control of such party, provided that such party uses reasonable efforts, under the circumstances, to notify the other party of the circumstances causing the delay and to resume performance as soon as possible.

  

	 	d.	 Construction. Section headings are for reference purposes only and should not be used in the
interpretation of this Agreement. No provision of this Agreement will be construed against either party as the drafter thereof. Each party has had the opportunity to consult with counsel in the negotiation of this Agreement. If any provision of this
Agreement is determined by a court of competent jurisdiction to be invalid, illegal or unenforceable, such determination will not impair or affect the validity, legality or enforceability of the remaining provisions of this Agreement, and such
provision will be changed and interpreted to accomplish the objectives of such provision to the greatest extent possible under applicable law. 

  

	 	e.	 Notices. All notices and other communications required or permitted to be given under this Agreement
shall be given in writing. Notices to Placer shall be sent to Placer Labs Inc., 340 Lemon Avenue #1277, Walnut, CA 91789, [***]. Notices to Life360 shall be sent to Life360 Inc., 539 Bryant Street, Suite 402, San Francisco CA 94107, [***]. Notices
shall be sent by certified mail, delivered by a nationally recognized courier service, delivered by hand, or sent by email, and are deemed to have been received when they are delivered by courier, hand delivered, or emailed, or five business days
after the date of mailing. Either party may change its address by giving notice of the new address to the other party in writing. 

  

	 	f.	 Governing Law; Venue. This Agreement shall be governed by, and construed in accordance with, the laws of
the State of California, without reference to conflicts of laws principles that would require the application of the laws of a different jurisdiction. The parties agree that the federal and state courts in California will have exclusive jurisdiction
and venue under this Agreement, and each party irrevocably submits to such jurisdiction exclusively and the parties hereby waive all defenses based upon forum nonconveniens, improper venue, or personal jurisdiction. The United Nations Convention on
Contracts for the International Sale of Goods will not apply to the Agreement. If a dispute arising under this Agreement results in litigation, the non-prevailing party shall pay the court costs and reasonable
attorneys’ fees of the prevailing party. Notwithstanding anything to the contrary in 

  
 16 

 EXECUTION VERSION 

 

	 	
this Agreement, either party has the right to apply to any court of competent jurisdiction for provisional relief, including pre-trial attachments, a
temporary restraining order, temporary injunction, permanent injunction and/or order of specific performance, without posting a bond, as may appear reasonably necessary to protect its Confidential Information or its proprietary rights.

  

	 	g.	 Entire Agreement and Language. This Agreement, including the Cover Sheet and any exhibits attached
hereto or incorporated herein, constitutes the entire understanding between the parties concerning the subject matter hereof and supersedes all prior and/or contemporaneous discussions, contracts and representations, whether oral or written and
whether or not executed by Placer and Life360. This Agreement or any part or provision hereof shall not be deemed waived, amended, or modified by either party unless such waiver, amendment or modification is in writing and executed by authorized
representatives of both parties. This Agreement shall be executed in English and any other language versions shall be for convenience only. 

  

	 	h.	 Counterparts. This Agreement may be executed in counterparts, each of which will be considered an
original and all of which together will constitute the same instrument, and may be executed by facsimile or electronic signature. 

  

	 	i.	 Force Majeure. Neither party shall be responsible for the delay in performance or failure to perform any
of its obligations in the Agreement, if the delay or failure results from a Force Majeure and the effect therefrom. “Force Majeure” means: natural catastrophes such as earthquake, volcano eruption, and tsunami, epidemic,
pandemic, war, invasion, act of terrorism, riot or civil unrest, labor strike, embargoes, telecommunications or internet failures. Each party, as applicable, shall endeavor to continue to perform its obligations as soon as practicable.

  

	 	j.	 [***] 

  
 17 

 EXECUTION VERSION 

 

 ATTACHMENT B 

Data Types 
 [***] 

  
 18 

 EXECUTION VERSION 

 

 ATTACHMENT C 

DPS Covenants and Services 
 [***] 

  
 19 

 EXECUTION VERSION 

 

 ATTACHMENT C-1 

[***] 

  
 20 

 EXECUTION VERSION 

 

 ATTACHMENT C-2 

[***] 

  
 21 

 EXECUTION VERSION 

 

 ATTACHMENT D 

FEES 
 Life360 Fees: 

Placer shall pay Life360 as follows: 
  

	 	a.	 During the Term, on the Effective Date and on the same date of each month thereafter until the first day of
calendar month after the calendar month in which Exclusivity Payment Date occurs (the “Fully Exclusive Date”), Placer shall pay Life360 a flat fee of $[***] per month. “Exclusivity Payment Date” means
the earlier of: (i) the date on which all Pre-existing Agreements have been terminated; and (ii) the date that is ninety-three (93) days after the Effective Date. 

 

	 	b.	 During the Term, starting after the Fully Exclusive Date and after the first day each calendar month
thereafter, Placer shall pay Life360 a flat fee of $[***] in accordance with Section 5 of this Agreement. 

  

	 	c.	 [***] 

Placer Fees: 
 Commencing on the Fully Exclusive
Date, and assuming the Placer Data Processing Services are ready to be provided to Life360 on that date, Life360 shall pay Placer $[***] on a calendar monthly basis, with payment to made within thirty (30) days of the end of each calendar month
for the Placer Services. 

  
 22 

 EXECUTION VERSION 

 

 ATTACHMENT E 

[***] 

  
 23 

 EXECUTION VERSION 

 

 ATTACHMENT F 

Placer Analytics Platform - ORDER FORM 

Analytics to be provided by Placer to Life360: 
  

	 	•	 	 Access, via Placer’s Platform, to reports, including Visits, Trade Areas, Customer Journey, Customer
Insights, Dwell Times, and Visitation by Hour/Day 

  

	 	•	 	 Actionable insights include: 

 

	 	•	 	 Accurate foot traffic counts and dwell time 

 

	 	•	 	 True Trade Areas displaying frequent-visitors-density by home and work locations 

 

	 	•	 	 Customers’ demographics, interests, and time spent at relevant locations 

 

	 	•	 	 Where customers are coming from and going to, and the routes they take 

 

	 	•	 	 Benchmarking of Foot Traffic, Market Share, Audiences, and other key metrics 

 

	 	•	 	 Competitive insights 

  

	 	•	 	 Void Analysis Reports 

  

	 	•	 	 Premier Customer Support 

 

	 	•	 	 Regular meetings with Placer’s Customer Success Team 

 

	 	•	 	 Live, Virtual Training support as reasonably needed 

 

	 	•	 	 Provide ad-hoc insights services to Life360, for PR purposes.

  

	 	•	 	 Examples of insights and analytics include: 

 

	 	•	 	 The ability to see how commutes change by major metro region (e.g., how the average time between leaving home and
arriving at work is changing day by day); 

  

	 	•	 	 Key statistics on overall movement behavior (e.g., where families are spending their time, such as going to
sporting events, staying at home socializing, going to movies etc.). 

 Full access and use of future services and features to the extent
they are provided to the existing customers of Placer for no additional fee (the “Basic Package”). For clarity, certain potential future features, such as incorporating 3rd party components, may be provided to existing
customers for an additional fee, and they are excluded from the Basic Package. 

  
 24 

 EXECUTION VERSION 

 

 Without limiting the terms of the Agreement, including Section 3.d, the Aggregated Data made available
to Life360 through the Placer Analytics Platform are the data, information and materials described above and shall be referred to as “Placer Provided Aggregated Data. Subject to Section 3.d, Life360 may use Placer Provided
Aggregated Data solely for the following purposes: (a) Life360 may use Placer Provided Aggregated Data for Life360’s internal business purposes, including development of its products and services, to incorporate in features within its app,
to display to its users and for marketing, advertising and PR purposes; and (b) Life360 may incorporate Placer Provided Aggregated Data into Research Data, as described and subject to the restrictions below. 

“Research Data” means datasets and other materials created by Life360 that result in any part from Life360’s use of Placer
Provided Aggregated Data. Life360 may share Research Data with current and potential Life360 customers, and in marketing materials; provided that Life360 shall cite Placer as a provider of such information. Life360 shall not, directly or indirectly,
resell, distribute, sublicense, display or otherwise provide Placer Provided Aggregated Data to any third parties, except that Life360 may display Placer Provided Aggregated Data as part of Research Data. 

Use of Placer Provided Aggregated Data is governed by, and Life360 and Placer agree to, the License Agreement located at
https://www.placer.ai/placer-license-agreement (“Placer Analytics Platform Access License Agreement”). Unless otherwise defined herein, capitalized terms herein have the same meaning as in said Placer Analytics Platform
Access License Agreement. 

  
 25 

 EXECUTION VERSION 

 

 ATTACHMENT G 

DELIVERY AND INFORMATION SECURITY TERMS 

[***] 

  
 26 

 EXECUTION VERSION 

 

 ATTACHMENT H 

Permitted Exclusions 
 This
Attachment H is attached to, and made 
 part of, this Agreement. 

 

	1.	 “Permitted Exclusions” means: (A) Life360’s agreement(s) to provide
Restricted Data to Arity 875, LLC (“Arity”) [***]; (B) [***]; (C) [***]; and (D) [***]: 

  

	    	 [***] 

  

	2.	 [***] 

  

	3.	 [***] 

  

	4.	 [***] 

  

	5.	 [***] 

  

	6.	 [***] 

  

	7.	 [***] 

  

	8.	 [***] 

  

	9.	 Life360 shall use commercially reasonable efforts to notify Placer in writing as expeditiously as possible (but
in no event more than seventy-two (72) hours) after becoming aware of its material breach of the exclusivity requirements in Section 3.d (and including this Attachment H). If Life360 breaches its
exclusivity requirements in Section 3.d (and including this Attachment H) and fails to cure such breach within thirty (30) days of receiving notice of the same from Placer, Life360 will pay Placer liquidated damages in the amount of twenty
million dollars ($20,000,000). The parties intend that the liquidated damages constitute compensation, and not a penalty. The parties acknowledge and agree that Placer’s harm caused by a breach by Life360 of the exclusivity provisions would be
impossible or very difficult to accurately estimate as of the Effective Date, and that the liquidated damages are a reasonable estimate of the anticipated or actual harm, including any non-direct damages.

  
 27 

 EXECUTION VERSION 

 

 ATTACHMENT I 

Form of Attestation 
 [***] 

  
 28

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00345-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00345-of-00352.parquet"}]]